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The Mechanoenzymatic Properties of Drp1 in Nucleotide Induced
Constriction of Lipid Bilayers
Christopher A. Francy, Frances J.D. Alvarez, Louie Zhou, Jason A. Mears.
Pharmacology, Case Western Reserve University, Cleveland, OH, USA.
Mitochondria are dynamicorganelles that continually undergocyclesof fission and
fusion. Dynamin-related protein 1 (Drp1), an 81 kDaGTPase, is themainmediator
of mitochondrial fission. In order to mediate fission, Drp1 is thought to form large
oligomers in the presence of nucleotide on the outer mitochondrial membrane.
Using sedimentation assays and electron microscopy, we confirm that Drp1 self-
assembles in the presence of either or both nucleotide and artificial lipid bilayers
in vitro. We further identify these oligomeric species as conformationally distinct
structures. Drp1 constricts lipid bilayers through a mechanism that requires GTP
hydrolysis. Following constriction, Drp1 disassembles and can reassociate with
lipid bilayers. Here we also show that the variable domain (VD) is not required
for lipid association. Rather, it limits Drp1 oligomerization and aids in oligomer
curvature. Our results support the conclusion that Drp1 is a mechanoenzymatic
protein regulated through distinct interactions with nucleotide and liposomes.
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Caveolin Revealed: A Mutagenesis Study of Caveolin-1
Sarah Plucinsky, Kerney J. Glover.
Lehigh University, Bethlehem, PA, USA.
Caveolae are 50-100 nm invaginations in the plasma membrane that are rich in
cholesterol, sphingomyelin and the integral membrane protein called caveolin-
1. Caveolin-1 has three main functions: forming caveolae, cell signaling, and
endocytosis. To examine the importance of conserved residues within the scaf-
folding and intra-membrane domains of caveolin-1, alanine and phenylalanine
scanning mutagenesis was performed on conserved residues. These residues
were identified by sequence alignment of the three caveolin isoforms. Sixteen
residues (S88, F92, K96, Y97, Y100, L103, P110, A112, G116, F119, A120,
S123, H126, I127, W128 and P132) were mutated individually to both alanine
and phenylalanine and subjected to analysis by NMR spectroscopy (1H-15N-
HSQC). The effect of the mutation on the overall protein structure was moni-
tored by comparison to the wild-type spectrum. These mutagenesis studies
reveal seven residues (Y100, P110, A112, G116, S123, H126, and P132) that
are structurally significant. The residues within the scaffolding domain are
more permissive to mutation than the intra-membrane domain. The proline res-
idues within the intra-membrane domain were shown to be critical for protein
structure. These findings shed light onto the structurally relevant residues
within the caveolin-1 scaffolding and intra-membrane domains, and further
our understanding of the requirements for protein structure and stability.
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Reconstitution and Topological Analysis of Caveolin-1 in Bicelles
Kyle Root.
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Caveolae are 50-100 nm invaginations in the plasma membrane of many cell
types that play a critical role in signal transduction. Caveolin-1 is a 21 kD integral
membrane protein that is required for the formation of caveolae. Caveolin-1 is
thought to adopt an unusual horseshoe topology in the membrane where the N-
and C- termini are cytoplasmic. Caveolin-1 has 4 native tryptophan residues in
this region (W85, W98, W115, and W128) that can be used as reporters of the
micro-environment of the polypeptide chain. Caveolin-1 single tryptophan mu-
tants were successfully reconstituted into CHAPSO/DMPC bicelles. Fluores-
cence emission measurements were performed on each mutant and analysis of
these spectra indicated that tryptophan residues 85 and 128 are in the head group
region of the lipid bilayer with lmax values of 344.4 5 2.4 nm and 338.2 5
0.6 nm respectively, and tryptophan residues 98 and 115 are inserted into the
hydrophobic core with lmax values of 334.4 5 0.2 nm and 330.25 1.0 nm,
respectively. The information gleaned from these studies was supported by MD
simulations performed on caveolin-1 in aDMPCbilayer. These data together sup-
port the postulation that caveolin-1 contains a membrane embedded turn.
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Fragment-Based Drug Design Approach for Targeting Phospholipid
Biosynthesis Pathway in Plasmodium Falciparum
Ewelina Guca1, Marina Lavigne1, Franc¸ois Hoh2, Jean-Franc¸ois Guichou2,
Christian Roumestand2, Henri Vial1, Rachel Cerdan1.1DIMNP UMR 5235, University of Montpellier II, Montpellier, France,
2Centre de Biochimie Structurale, INSERM/CNRS UMR 5048, Montpellier,
France.
Phospholipid synthesis metabolic pathways in Plasmodium falciparum are vali-
dated drug targets for new type of antimalarials. In the de novo Kennedy
pathway of phosphatidylcholine biosynthesis, the second step catalyzed by
CTP:phosphocholine cytidylytransferases [2.7.7.15] is rate limiting and ap-
pears essential for the parasite survival at its blood stage. We are focused on
the structural characterization of this enzyme, the identification of effectors
by fragment-based drug design approach (FBDD) and then their optimization
to eventually design a lead. We solved the first reported crystal structure of
the catalytic domain of the enzyme target (PfCCT) at resolution 2.2 A˚ and
the enzyme-product (CDP-choline) complex structure at resolution 2.4 A˚ that
give detailed images of binding pocket and demonstrate conformational
changes between apo- and holo-protein forms at atomic level. The FBDD
method uses a library of small molecules (fragments) with molecular weight
that does not exceed 300 Da to explore target binding sites. Primary screening
of fragment library (230 molecules) has been investigated by fluorescence-
based thermal shift assay and Nuclear Magnetic Resonance Saturation Transfer
Difference (NMR STD) method is used as a secondary screen to eliminate false
positive ligands. This combination of techniques identified so far 4 fragment
hits that are currently evaluated for their binding modes and affinities. Co-
crystallization of the protein-fragments complexes is carrying out to provide
accurate information on the binding modes of the small molecules and topology
of interactions will be used to rationally monitor every iterative round of the
optimization process allowing subsequent rational design.
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Mechanisms of Pin1 Regulation of IRAKM Stability in Toll-Like Recep-
tor/Interleukin-1 Receptor Signaling
Jeahoo Kwon1, Morris Nechama2, Kun Ping Lu2, Linda K. Nicholson1.
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The molecular mechanisms of asthma, a chronic inflammatory sickness that in-
volves activation of the innate immunity signaling pathways, are not yet fully
understood. Our studies focus on the peptidyl-prolyl isomerase enzyme Pin1
and its substrates in innate immunity signaling. Prolyl peptide bonds, such as
in pS/T-P motifs, can exist in two distinct isomer conformations, cis and trans,
that exchange on a slow time scale (several minutes). Isomerization of pS/T-P
motifs can be accelerated by Pin1. Pin1 has recently been shown to be activated
by IL-33 which activates IL-1R signaling in Th2 cells, inducing asthma. Pin1
knockout (KO -/-) abolishes Th2 cytokine release thereby preventing asthma
symptoms. Pin1 also prevents degradation of IRAKM, a negative regulator
of TLR/IL-1R signaling, but promotes the nuclear localization of IRAKM.
IRAKM is phosphorylated upon IL-33 treatment. The phosphomimetic muta-
tion IRAKM S110E is dramatically stabilized in a Pin1-dependent manner,
even more than wild type IRAKM. We test the model that Pin1 regulation of
IRAKM stability and nuclear localization is mediated by the direct interaction
of Pin1 with phosphorylated IRAKM. The dissociation constants, KD, for Pin1
binding to phosphorylated IRAK-M (pIRAKM) and to the phosphomimetic
mutation IRAKM S110E were determined using the 1H 15N HSQC NMR
experiment. Furthermore, the Pin1 catalyzed isomerization of wild type
pIRAKM and IRAKM S110E were measured using the ROESY NMR exper-
iment. This study is expected to contribute to our understanding of the novel
mechanism of Pin1 regulation of the TLR/IL-1R signaling pathway in terms
of specific domains of IRAKM.
1869-Pos Board B6
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Dimerization of epidermal growth factor receptor (EGFR/ErbB) homologs is
necessary for their activation. Dysregulation of each of these receptors is linked
to a variety of cancers. Most members of this protein family adopt a tethered
conformation in the absence of ligand that prevents the formation of active di-
mers, while ErbB2 adopts a constitutively extended conformation mimicking
the ligand-bound conformation. Surprisingly, ErbB2 does not homodimerize
yet is the preferred dimerization partner of the other EGFR homologs. The rea-
sons for this are unclear, and previous attempts to address these questions using
structural techniques were unsuccessful. Here we drove dimerization of the
extracellular domains of EGFR family members with ErbB2 by fusion of
one extracellular domain to the light and the other to the heavy chain of an
